These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37031355)

  • 1. Humoral and Cellular Immune Response Elicited by Two Doses of mRNA BNT162b2 Vaccine Against SARS-CoV-2 in People Living with HIV.
    Vanetti C; Milazzo L; Ardizzone F; Oreni L; Cappelletti G; Trabattoni D; Biasin M
    AIDS Res Hum Retroviruses; 2023 Sep; 39(9):495-499. PubMed ID: 37031355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study.
    Wolff M; Charpentier P; Canals A; Vial C; Hormazábal J; Cortés J; Silva M
    Vaccine; 2024 Jan; 42(3):671-676. PubMed ID: 38123398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count.
    Antinori A; Cicalini S; Meschi S; Bordoni V; Lorenzini P; Vergori A; Lanini S; De Pascale L; Matusali G; Mariotti D; Cozzi Lepri A; Gallì P; Pinnetti C; Gagliardini R; Mazzotta V; Mastrorosa I; Grisetti S; Colavita F; Cimini E; Grilli E; Bellagamba R; Lapa D; Sacchi A; Marani A; Cerini C; Candela C; Fusto M; Puro V; Castilletti C; Agrati C; Girardi E; Vaia F;
    Clin Infect Dis; 2022 Aug; 75(1):e552-e563. PubMed ID: 35366316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy.
    Jedicke N; Stankov MV; Cossmann A; Dopfer-Jablonka A; Knuth C; Ahrenstorf G; Ramos GM; Behrens GMN
    HIV Med; 2022 May; 23(5):558-563. PubMed ID: 34725907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cell-mediated immune responses in HIV-vertically infected young patients after three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine.
    Vanetti C; Stracuzzi M; Crivellaro E; Ciciliano F; Garziano M; Fenizia C; Biasin M; Rubinacci V; Amendola A; Tanzi E; Zuccotti GV; Clerici M; Giacomet V; Trabattoni D
    Front Immunol; 2023; 14():1301766. PubMed ID: 38250079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV.
    El Moussaoui M; Desmecht S; Lambert N; Maes N; Braghini J; Marechal N; Quintana C; Briquet K; Gofflot S; Toussaint F; Hayette MP; Vermeersch P; Lutteri L; Grégoire C; Beguin Y; Rahmouni S; Moutschen M; Desmecht D; Darcis G
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV).
    Woldemeskel BA; Karaba AH; Garliss CC; Beck EJ; Wang KH; Laeyendecker O; Cox AL; Blankson JN
    Clin Infect Dis; 2022 Apr; 74(7):1268-1270. PubMed ID: 34293114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered.
    López-Cortés LF; Saborido-Alconchel A; Trujillo-Rodríguez M; Serna-Gallego A; Llaves-Flores S; Muñoz-Muela E; Pérez-Santos MJ; Lozano C; Mejias-Trueba M; Roca C; Espinosa N; Gutiérrez-Valencia A
    Front Immunol; 2023; 14():1129753. PubMed ID: 37006309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy.
    Datwani S; Kalikawe R; Waterworth R; Mwimanzi FM; Liang R; Sang Y; Lapointe HR; Cheung PK; Omondi FH; Duncan MC; Barad E; Speckmaier S; Moran-Garcia N; DeMarco ML; Hedgcock M; Costiniuk CT; Hull M; Harris M; Romney MG; Montaner JSG; Brumme ZL; Brockman MA
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients.
    Oyaert M; De Scheerder MA; Van Herrewege S; Laureys G; Van Assche S; Cambron M; Naesens L; Hoste L; Claes K; Haerynck F; Kerre T; Van Laecke S; Van Biesen W; Jacques P; Verhasselt B; Padalko E
    Front Immunol; 2022; 13():858399. PubMed ID: 35401575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approach.
    Montesi G; Augello M; Polvere J; Marchetti G; Medaglini D; Ciabattini A
    J Transl Med; 2024 May; 22(1):432. PubMed ID: 38715088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study.
    Manni S; Ruetsch C; Fabre R; Ticchioni M; Graça D; Pradier C; Seitz-Polski B; Lotte L; Brglez V; Vassallo M
    Front Immunol; 2023; 14():1136723. PubMed ID: 36949938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study.
    Cassaniti I; Bergami F; Percivalle E; Gabanti E; Sammartino JC; Ferrari A; Adzasehoun KMG; Zavaglio F; Zelini P; Comolli G; Sarasini A; Piralla A; Ricciardi A; Zuccaro V; Maggi F; Novazzi F; Simonelli L; Varani L; Lilleri D; Baldanti F
    Clin Microbiol Infect; 2022 Feb; 28(2):301.e1-301.e8. PubMed ID: 34582981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants.
    Chiu CH; Chang YH; Tao CW; Chang FY; Chiu KC; Chang TW; Yen LC
    Microbiol Spectr; 2022 Oct; 10(5):e0060922. PubMed ID: 36005765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.
    Motsoeneng BM; Manamela NP; Kaldine H; Kgagudi P; Hermanus T; Ayres F; Makhado Z; Moyo-Gwete T; van der Mescht MA; Abdullah F; Boswell MT; Ueckermann V; Rossouw TM; Madhi SA; Moore PL; Richardson SI
    Front Immunol; 2023; 14():1231276. PubMed ID: 37600825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy.
    Podrazil M; Taborska P; Stakheev D; Rataj M; Lastovicka J; Vlachova A; Pohunek P; Bartunkova J; Smrz D
    Front Immunol; 2022; 13():892277. PubMed ID: 35669765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients.
    Davidovic T; Schimpf J; Abbassi-Nik A; Stockinger R; Sprenger-Mähr H; Lhotta K; Zitt E
    Front Immunol; 2022; 13():907615. PubMed ID: 35812459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH).
    Tuan JJ; Zapata H; Barakat L; Andrews L; Behnegar A; Kim YW; Kayani J; Mutic S; Ryall L; Turcotte B; Critch-Gilfillan T; Zhao M; Salahuddin S; Gupta S; Sutton R; Friedland G; Emu B; Ogbuagu O
    BMC Infect Dis; 2022 Sep; 22(1):744. PubMed ID: 36131232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The humoral and cellular immune responses following booster vaccination with SARS-CoV-2 mRNA in people living with human immunodeficiency virus.
    Matsumoto Y; Murata M; Ohta A; Yamasaki S; Ikezaki H; Toyoda K; Shimono N
    J Infect Chemother; 2024 May; 30(5):417-422. PubMed ID: 37977325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV.
    Marchitto L; Chatterjee D; Ding S; Gendron-Lepage G; Tauzin A; Boutin M; Benlarbi M; Medjahed H; Sylla M; Lanctôt H; Durand M; Finzi A; Tremblay C
    Viruses; 2023 Sep; 15(10):. PubMed ID: 37896781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.